Schifano, Fabrizio

Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies

Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 727

Novel psychoactive substances of interest for psychiatry

Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 321

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology

Pharmacovigilance and Adverse Drug ReactionsSubstance Abuse Treatment and Outcomes

Cited by 194

A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database

Chiappini, S., & Schifano, F. (2016) · CNS Drugs

Opioid Use Disorder TreatmentPharmacovigilance and Adverse Drug Reactions

Cited by 189

From “Special K” to “Special M”: The Evolution of the Recreational Use of Ketamine and Methoxetamine

Corazza, O., Assi, S., & Schifano, F. (2013) · CNS Neuroscience & Therapeutics

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 146

New/emerging psychoactive substances and associated psychopathological consequences

Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021) · Psychological Medicine

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 119

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Arillotta, D., Floresta, G., Guirguis, A., Corkery, J. M., Catalani, V., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Brain Sciences

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 104

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review

Orsolini, L., Papanti, G. D., De Berardis, D., Guirguis, A., Corkery, J. M., & Schifano, F. (2017) · Frontiers in Psychiatry

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 99

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use

Corkery, J. M., Loi, B., Claridge, H., Goodair, C., Corazza, O., Elliott, S., & Schifano, F. (2015) · Neuroscience & Biobehavioral Reviews

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 98

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Chiappini, S., Vickers-Smith, R., Harris, D., Papanti Pelletier, G. D., Corkery, J. M., Guirguis, A., Martinotti, G., Sensi, S. L., & Schifano, F. (2023) · Pharmaceuticals

Pharmacovigilance and Adverse Drug ReactionsPharmacology and Obesity Treatment

Cited by 78

The clinical challenges of synthetic cathinones

Schifano, F., Napoletano, F., Arillotta, D., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J. M., & Vento, A. (2020) · British Journal of Clinical Pharmacology

Forensic Toxicology and Drug AnalysisPoisoning and overdose treatments

Cited by 73

Profiling online recreational/prescription drugs' customers and overview of drug vending virtual marketplaces

Orsolini, L., Francesconi, G., Papanti, D., Giorgetti, A., & Schifano, F. (2015) · Human Psychopharmacology Clinical and Experimental

Cybercrime and Law Enforcement StudiesPharmaceutical Quality and Counterfeiting

Cited by 70

MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series

Schifano, F., & Magni, G. (1994) · Biological Psychiatry

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 58

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology

Pharmacovigilance and Adverse Drug ReactionsOpioid Use Disorder Treatment

Cited by 55

Pregabalin Misuse–Related Issues; Intake of Large Dosages, Drug-Smoking Allegations, and Possible Association With Myositis: Two Case Reports

Carrus, D., & Schifano, F. (2012) · Journal of Clinical Psychopharmacology

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 49

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

Schifano, F., & Chiappini, S. (2018) · PLOS ONE

Pharmacovigilance and Adverse Drug ReactionsPoisoning and overdose treatments

Cited by 44

Is There a Potential of Misuse for Quetiapine?: Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database

Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 44

Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance‐related psychotic symptoms

Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G., & Schifano, F. (2015) · Human Psychopharmacology: Clinical and Experimental

Forensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

Cited by 41

Is There a Potential of Misuse for Venlafaxine and Bupropion?

Schifano, F., & Chiappini, S. (2018) · Frontiers in Pharmacology

Pharmacovigilance and Adverse Drug ReactionsOpioid Use Disorder Treatment

Cited by 38

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario

Arillotta, D., Schifano, F., Napoletano, F., Zangani, C., Gilgar, L., Guirguis, A., Corkery, J. M., Aguglia, E., & Vento, A. (2020) · Frontiers in Neuroscience

Forensic Toxicology and Drug AnalysisOpioid Use Disorder Treatment

Cited by 37

Pregabalin: A range of misuse‐related unanswered questions

Schifano, F., & Chiappini, S. (2019) · CNS Neuroscience & Therapeutics

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 36

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

Chiappini, S., Schifano, F., Corkery, J. M., & Guirguis, A. (2020) · Brain Sciences

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 33

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?

Orsolini, L., St John-Smith, P., McQueen, D., Papanti, D., Corkery, J., & Schifano, F. (2017) · Current Neuropharmacology

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 28

Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse

Quaglio, G., Schifano, F., & Lugoboni, F. (2008) · Addiction

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 21